Cognitive Bias in Fibromyalgia. Why a Full Assessment Still Matters.

Clinicians often assume their diagnostic reasoning is grounded in evidence. In reality, the human brain relies on pattern recognition and cognitive shortcuts, known as cognitive biases, which subtly influence nearly every diagnosis. This phenomenon is particularly consequential in fibromyalgia, a condition lacking confirmatory laboratory tests or definitive imaging, and characterized by symptoms that overlap with numerous other diseases. Consequently, fibromyalgia represents a context in which diagnostic reasoning is especially susceptible to error.

One clarification up front: Fibromyalgia is no longer a diagnosis of exclusion. The 2016 revision to the American College of Rheumatology criteria deliberately removed the previous requirement to rule out other conditions first, stating that a diagnosis of fibromyalgia is valid regardless of other diagnoses and does not preclude the presence of other clinically important illnesses [1]. In other words, a clinician does not have to chase down and eliminate every alternative before naming fibromyalgia. But that is precisely why a proper history and physical still matter to earn the right to diagnose fibromyalgia. Still, because fibromyalgia so often travels alongside other conditions, the label must never become a reason to stop looking. We still owe every patient a thorough assessment.

This article examines common cognitive biases that distort differential diagnosis, illustrates their specific manifestations in fibromyalgia, and argues for two essential safeguards that cannot be replaced by algorithms: comprehensive health history and physical assessment, and a commitment to ongoing reassessment.

A quick primer on cognitive bias. 

A cognitive bias is a systematic deviation from rational judgment, representing a mental shortcut (heuristic) that generally aids decision-making but can also lead to predictable errors. In medicine, these shortcuts are both unavoidable and frequently beneficial; for example, an experienced clinician may quickly identify a classic presentation using heuristics. However, the efficiency of such shortcuts can lead to errors when a case does not conform to expected patterns. Fibromyalgia exemplifies such a scenario.

The following table, adapted from biases commonly cited in clinical reasoning curricula, provides a useful framework. Each bias will be examined in the context of fibromyalgia.

Fibromyalgia is a magnet for bias in both directions.

Two characteristics of fibromyalgia contribute to its heightened susceptibility to diagnostic reasoning errors.

Diagnosis rests on the American College of Rheumatology criteria: widespread pain lasting at least three months alongside characteristic fatigue, cognitive difficulty, and sleep disturbance, with laboratory and imaging studies used not to confirm fibromyalgia but to exclude the conditions that mimic it [1, 2]. When there is no positive test, the diagnosis is only as good as the reasoning behind it.

Its symptoms overlap heavily with serious, treatable diseases. Widespread pain and fatigue are shared by hypothyroidism, vitamin D deficiency, rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, myofascial pain syndrome, and even medication side effects from agents such as statins [3]. Fibromyalgia can also coexist with these conditions rather than replace them, which is exactly where search satisfaction becomes dangerous.

This dynamic creates a dual challenge. Cognitive bias may result in missed diagnoses, with fibromyalgia a genuine and disabling condition being dismissed as stress or anxiety for extended periods. Conversely, bias may lead to over-attribution, where fibromyalgia is assigned as a convenient diagnosis, potentially obscuring underlying conditions such as lupus, thyroid disease, or early inflammatory arthritis.

The “missed” direction: how bias delays a real diagnosis.

The numbers here are sobering. Real-world data from a large healthcare database found a mean time from initial complaints to fibromyalgia diagnosis of roughly six years [4]. Patient surveys tell a similar story: people often see multiple physicians over years before receiving a diagnosis, with one survey reporting an average of about 2.3 years and 3.7 physicians [5].

This scenario exemplifies anchoring and framing biases. Historically, patients, most often women, present with diffuse pain and fatigue. The initial impression, such as attributing symptoms to stress or anxiety, anchors the clinical encounter, and this framing persists in the medical record. Diagnostic momentum perpetuates the bias, as subsequent clinicians inherit and rely on the prior label rather than conducting an independent assessment.

Delay is not harmless. Studies of diagnostic delay in fibromyalgia have found that earlier diagnosis is associated with lower symptom severity, while very late diagnosis correlates with worse impact scores [6, 7]. In other words, the biases that stall a diagnosis may also be worsening the disease they failed to name.

The “over-attribution” direction: how bias hides something worse.

The converse error is less conspicuous but potentially more hazardous. Once fibromyalgia is documented in the medical record, premature closure and search satisfaction may lead clinicians to attribute any new symptom to fibromyalgia. For example, rising inflammatory markers, new joint swelling, or abnormal thyroid function tests may be overlooked or dismissed.

Multicenter data show that late diagnosis and misdiagnosis of fibromyalgia are common and underestimated problems, with conditions such as rheumatoid arthritis, spondyloarthropathies, and connective tissue disease frequently confused with it [8]. A published case report captures the stakes: a woman in her late thirties with chronic widespread pain and a complex history required repeated labs and imaging, and fibromyalgia was reached only after the common causes of diffuse pain were systematically ruled out [3]. That sequence rule out first, label second is the antidote to search satisfaction.

The impact of representativeness bias.

The “typical” fibromyalgia patient in most clinicians’ minds is a middle-aged woman, and historically 80–90% of diagnoses under older criteria were in women [9]. But that figure may itself partly reflect diagnostic bias rather than true biology. Newer criteria and greater awareness are identifying more men, suggesting the condition was underdiagnosed in men all along [9]. Meanwhile, one analysis of U.S. ambulatory data found non-White individuals had substantially lower odds of a fibromyalgia diagnosis than White individuals, a disparity the authors could not fully explain and flagged as possible external diagnostic bias [10]. Representativeness, in short, doesn’t just cause individual errors, it can systematically shape who gets diagnosed at all.

A compounding factor is that physicians’ knowledge of the diagnostic criteria themselves is inconsistent. In one study, roughly half of physicians surveyed did not adhere to any formal criteria and instead relied on clinical acumen, and knowledge of the criteria was often poor conditions under which bias flourishes [11].

The two safeguards bias cannot survive.

Given that cognitive biases are automatic and unavoidable, two primary strategies serve to protect patients.

1. A comprehensive history and physical assessment.

The single most powerful debiasing tool is also the oldest: a thorough, structured history and physical exam. Anchoring, availability, and framing all thrive on incomplete information; they fill the gaps with assumptions. A complete history closes those gaps. It surfaces red-flag features that don’t fit fibromyalgia (objective joint swelling, fever, weight loss, focal neurologic findings) and prompts targeted labs to exclude mimics before a label is applied [1, 2].

In the context of fibromyalgia, the physical examination challenges representativeness bias by requiring clinicians to assess each patient individually rather than relying on preconceived prototypes. When assessments are rushed or omitted, the likelihood of cognitive bias increases.

2. Deliberate reassessment.

A diagnosis should be regarded as a hypothesis rather than a definitive conclusion. Diagnostic momentum and premature closure both operate under the assumption that the initial diagnosis is final, an assumption that regular reassessment is designed to counteract. Patients’ clinical presentations may evolve, new symptoms may develop, and coexisting conditions may become apparent over time. An accurate fibromyalgia diagnosis initially does not preclude the subsequent development of other conditions, such as lupus.

Incorporating regular reassessment into clinical practice, such as periodically evaluating whether the current diagnosis remains appropriate and identifying any new or unexplained symptoms, is essential for detecting treatable conditions that an existing label may obscure. This approach serves as a structural safeguard against search satisfaction. For patients, maintaining a symptom journal and explicitly reporting new or changing symptoms is particularly important, since alterations in symptom patterns may be overlooked due to clinician bias [12].

The takeaway.

Cognitive bias is inherent to human cognition and affects both experienced and novice clinicians. The distinction between accurate diagnosis and bias-driven error lies not in avoiding cognitive shortcuts, but in implementing effective safeguards. In the context of fibromyalgia, where diagnostic uncertainty is high and symptom overlap with serious conditions is common, these safeguards are essential: comprehensive history and physical examination, exclusion of alternative diagnoses before labeling, and ongoing reassessment throughout the clinical course.

Patients with fibromyalgia warrant both validation of their experiences and thorough clinical evaluation. These commitments are complementary and, when upheld together, provide the strongest protection against cognitive biases that might otherwise prematurely determine the diagnosis.

—

References

1. Ferro Moura Franco K, et al. Fibromyalgia. StatPearls. NCBI Bookshelf; updated 2025. https://www.ncbi.nlm.nih.gov/books/NBK540974/
2. Kang JH, et al. Fibromyalgia: Diagnosis and Management. American Family Physician. 2023;107(2). https://www.aafp.org/pubs/afp/issues/2023/0200/fibromyalgia.html
3. From Years of Pain to a Name: Fibromyalgia Uncovered. Cureus / PMC. 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12790412/
4. Gendelman O, et al. Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care. Best Practice & Research Clinical Rheumatology. 2019. https://www.sciencedirect.com/science/article/abs/pii/S1521694219300208
5. Choy E, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Services Research. 2010. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874550/
6. Evaluating the Effect of Delayed Diagnosis on Disease Outcome in Fibromyalgia: A Multi-Center Cross-Sectional Study. 2023. https://pubmed.ncbi.nlm.nih.gov/37123049/
7. Salaffi F, et al. Delay in fibromyalgia diagnosis and its impact on the severity and outcome: a large cohort study. 2024. https://pubmed.ncbi.nlm.nih.gov/38966945/
8. Salaffi F, et al. Misdiagnosis in fibromyalgia: a multicentre study. Clinical and Experimental Rheumatology. https://pubmed.ncbi.nlm.nih.gov/22243557/
9. Fibromyalgia. Stanford Medicine, Division of Pain Medicine. Updated 2025. https://med.stanford.edu/pain/about/chronic-pain/fibromyalgia.html
10. The impact of changes in fibromyalgia diagnosis criteria: using NAMCS data (2010–2019). BMC Rheumatology. 2025. https://link.springer.com/article/10.1186/s41927-025-00483-1
11. Assessing our Approach to Diagnosing Fibromyalgia. PMC. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC11829810/
12. Common Misdiagnoses of Fibromyalgia. WebMD. 2024. https://www.webmd.com/fibromyalgia/common-misdiagnoses-of-fibromyalgia

This article is for professional and educational purposes and does not constitute individual medical advice.